BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 1353550)

  • 1. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
    Melo JV; Goldman JM
    Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.
    Nishigaki H; Misawa S; Inazawa J; Abe T
    Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transposition of the abl proto-oncogene in Philadelphia--negative chronic myeloid leukaemia and acute lymphocytic leukaemia.
    Stopera SA; Davie JR; Ray M
    Cytobios; 1990; 61(246-247):161-70. PubMed ID: 2163816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
    Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
    Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
    Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
    Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene.
    Mills KI; Sproul AM; Leibowitz D; Burnett AK
    Leukemia; 1991 Nov; 5(11):937-41. PubMed ID: 1961034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of reciprocal translocation in BCR-ABL positive Ph-negative chronic myeloid leukaemia.
    Lazaridou A; Chase A; Melo J; Garicochea B; Diamond J; Goldman J
    Leukemia; 1994 Mar; 8(3):454-7. PubMed ID: 8127150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
    Melo JV; Myint H; Galton DA; Goldman JM
    Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.
    Chien JH; Tang JL; Chen RL; Li CC; Lee CP
    Leuk Res; 2008 Nov; 32(11):1724-34. PubMed ID: 18603297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Philadelphia chromosome 30 years later].
    Lisker R
    Rev Invest Clin; 1992; 44(1):123-30. PubMed ID: 1523343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular pathology of chronic myelogenous leukaemia.
    Kurzrock R; Talpaz M
    Br J Haematol; 1991 Oct; 79 Suppl 1():34-7. PubMed ID: 1931706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
    Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
    Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
    Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
    Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.